Medspa Treatment Pricing Benchmarks (National & Regional)

Benchmark ranges reflect typical cash-pay pricing (not insurance-reimbursed procedures) reported by independent practices, franchise networks, and clinical surveys. Regional variation reflects cost of living, competition density, and patient demographics. Your actual pricing should account for: (1) your cost of goods (COGS) for injectables and devices; (2) your overhead (rent, staff, licensing, liability); (3) your provider credentials and reputation; (4) local competition and demand; (5) your business model (membership, package discounts, loyalty programs). Use these ranges to identify whether you are significantly above or below market—not to match them exactly. Adjust for your specific market conditions.

Botox and equivalent neurotoxins typically range $10–$15 per unit nationally, with regional variation from $8–$18. Full-face treatment (20–60 units) averages $200–$600. Forehead alone runs $100–$200; glabellar (frown lines) $100–$200; crow's feet $75–$150 per side. Dysport, Xeomin, and Jeuveau often price 10–15% lower than Botox due to brand positioning. Boey (trenibotulinumtoxinE), newly approved in Canada and pending U.S. clearance, is marketed as rapid-onset and short-duration; pricing will likely track near Botox once available. Regional premium: urban/coastal markets (NYC, LA, Miami, San Francisco) command 20–40% premiums; rural and secondary markets run 15–25% below national average. Practices using membership or package models often offer per-unit discounts (e.g., $12/unit for 60+ units).

Dermal filler pricing is typically per syringe (0.5–1.0 mL). Hyaluronic acid fillers (Juvederm, Restylane) range $400–$800 per syringe nationally; Restylane Contour (newly FDA-approved for temple hollowing) and Juvederm Voluma track at the higher end for volumizing indications. RHA Dynamic Volume (recently cleared for midface augmentation) enters at $500–$900 per syringe as a premium dynamic filler. Radiesse (calcium hydroxylapatite) runs $500–$900 per syringe. Sculptra (poly-L-lactic acid) is priced per vial ($600–$1,200) and typically requires 2–3 vials per session. Skinvive by Juvederm (newly FDA-approved for neck lines and 'tech neck') is priced per syringe at $600–$1,000. Regional variation: coastal and major metros 25–35% higher; secondary markets 15–25% lower. Practices often bundle or offer package pricing for multi-syringe treatments.

Laser and radiofrequency treatments vary widely by device type, treatment area, and session count. Full-face laser resurfacing (ablative or fractional) ranges $1,500–$4,000 per session; IPL photorejuvenation $400–$1,200 per session. Microneedling with radiofrequency (e.g., InMode devices) runs $800–$2,500 per session depending on area and intensity. Thread lifts range $1,500–$3,500 per treatment. Pricing is often quoted per session or per treatment course (e.g., 3–6 sessions). Device manufacturers (InMode, Cutera, Lumenis, Synergon) do not set retail prices; practices negotiate equipment costs and set their own service fees. Regional premiums are significant: major metropolitan areas 30–50% higher; rural markets 20–30% lower. Practices often offer package discounts for multi-session protocols (e.g., 10–15% off for prepaid 6-session courses).

Coastal and major metropolitan markets (New York, Los Angeles, Miami, San Francisco, Boston, Chicago) typically command 25–50% premiums over national averages due to higher cost of living, provider density, and patient wealth. Secondary markets (Austin, Denver, Phoenix, Charlotte, Nashville) run 5–15% above national average. Rural and tertiary markets run 15–30% below national average. State regulation, licensing requirements, and scope-of-practice laws also influence pricing: states with stricter nurse-injector regulations or higher malpractice insurance costs often see higher service fees. Competitive saturation matters: markets with many practices may compress pricing; underserved areas support premium positioning. Patient demographics (age, income, aesthetic preferences) and seasonal demand (pre-holiday, pre-summer) also drive variation.

Before setting or adjusting prices, audit your COGS (what you pay for product), your overhead allocation per procedure, and your target margin. Most profitable practices target 60–75% gross margin on injectables and 50–70% on energy-based treatments after accounting for product, staff, and facility costs. Consider your positioning: premium/luxury practices justify higher prices through reputation, provider credentials, and patient experience; volume-focused practices compete on accessibility and package deals. Monitor competitor pricing (mystery shop, check websites, ask patients) quarterly. Implement dynamic pricing cautiously: loyalty programs, package discounts, and seasonal promotions build patient lifetime value; deep discounting erodes brand positioning and attracts price-sensitive patients. Track pricing by treatment, region, and patient cohort to identify your most profitable and most competitive offerings. Adjust annually based on cost inflation, competitive changes, and demand.